Hypo-fractionated Stereotactic Body Radiotherapy in High Risk Prostate Cancer
Observational Trial: HR SBRT Prostate
A Study That Obtains Quality of Life Data after a Short Course of Radiation Therapy
Technical Title: A Study to Obtain Quality of Life Data after a Hypo-Fractionated Course of Stereotactic Body Radiotherapy for the Treatment of Localized High-Risk Prostate Cancer
UCLA Department of Radiation Oncology is conducting a study that researches the effect of hypo-fractionated radiotherapy, also known as stereotactic body radiotherapy (SBRT), for men with prostate cancer, which is considered high risk. SBRT is a routine treatment for prostate cancer pioneered at UCLA, which delivers five large doses of radiation rather than many small doses over a longer period of time. This study is designed to compare the quality of life outcomes for patients who opt for SBRT over the longer course of treatment.
All treatment that takes place on this study is considered routine. Patients will come to Radiation Oncology for a treatment planning session which requires a CT scan, then return about one week later to receive radiation to the pelvis on five separate occasions. Patients will return to Radiation Oncology for regular follow-up visits for up to five years. At all visits patients will be asked to complete quality of life questionnaires which ask about sexual health, urinary function and other personal issues pertinent to men being treated for prostate cancer.
For More Detailed Information Contact: